The RyR modulator dantrolene (Ryanodex) is an FDA approved medication that has been shown to be effective in reversing many of the synaptic and cognitive effects seen in mouse models of AD [8,114,115,116], and has good CNS penetration when given orally or by nasal administration [117]. Here, RYR2 is linked to Alzheimer disease.